Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 8, 2009, Pages 891-897

  Kuptniratsaikul, Vilai ^a   Thanakhumtorn, Sunee ^a   Chinswangwatanakul, Pornsiri ^a   Wattanamongkonsil, Luksamee ^a   Thamlikitkul, Visanu ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CURCUMA DOMESTICA EXTRACT; IBUPROFEN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURCUMA DOMESTICA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FATIGUE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; KNEE FUNCTION; KNEE OSTEOARTHRITIS; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; NAUSEA; NONHUMAN; PAIN ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT RESPONSE; VOMITING; WALKING; XEROSTOMIA;

AGED; CURCUMA; FEMALE; HUMANS; IBUPROFEN; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PHYTOTHERAPY; PLANT EXTRACTS; WALKING;

EID: 70350102346     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0186     Document Type: Article

References (27)

1. Felson DT, Naimark A, Anderson J, et al. The prevalence of knee osteoarthritis in the elderly: The Framingham osteoarthritis study. Arthritis Rheum 1987;30:914-918.
2. Kuptniratsaikul V, Tosayanonda O, Nilkanuwong S, et al. The epidemiology of knee osteoarthritis patients. J Med Assoc Thai 2002;85:154-161.
3. Lawrence RC, Hochberg MC, Kelsey JL, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989;16:427-441.
4. Murray CJL, Lopez AD. The Global Burden of Disease. Geneva: World Health Organization, 1997.
5. Rejeski WJ, Shumaker S. Knee osteoarthritis and health-related quality of life. Med Sci Sports Exerc 1994;26:1441-1445.
6. Zeidler H. Epidemiology and NSAID induced gastropathy. J Rheumatol 1991;28:2-5.
7. Gumbrevicius G, Milasius A, Sveikata A. Nonsteroidal antiinflammatory agents: Choice between disturbances of gastrointestinal tract and cardiovascular toxicity. Medicina (Kaunas) 2006;42:429-439.
8. Began G, Sudharshan E, Appu Rao AG. Inhibition of lipoxygenase 1 by phosphatidylcholine micelles-bound curcumin. Lipids 1998;33:1223-1228.
9. Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase- 2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 2001;172:111-118.
10. Yamamoto H, Hanada K, Kawasaki K, et al. Inhibitory effect on curcumin on mammalian phospholipase D activity. FEBS Lett 1997;417:196-198.
11. Joe B, Lokesh BR. Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids 1997;32: 1173-1180.
12. Singh S, Aggarwal BB. Activation of transcription factor NFkappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 1995;270:24995-25000.
13. Chan MM, Huang HI, Fenton MR, et al. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 1998;55:1955-1962.
14. Brouet I, Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995;206:533-540.
15. Jackson JK, Higo T, Hunter WL, et al. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res 2006;55:168-175.
16. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J Altern Complement Med 2003;9:161-168.
17. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-1049.
18. Hauck WW, Anderson S. Some issues in the design and analysis of equivalence trials. Drug Inf J 1999;33:109-118.
19. Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 2004;44:97-111.
20. Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006;1: CD004257.
21. Lee C, Straus WL, Balshaw R, et al. A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: A meta-analysis. Arthritis Rheum 2004;51:746-754.
22. Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol 1986;24:651-654.
23. Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 1980;71:632-634.
24. Funk JL, Oyarzo JN, Frye JB, et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod 2006;69:351-355.
25. Little CV, Parsons T. Herbal therapy for treating osteoarthritis. Cochrane Database Syst Rev 2001;1:CD002947.
26. Abernethy DR, Greenblatt DJ. Ibuprofen disposition in obese individuals. Arthritis Rheum 1985;28:1117-1121.
27. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with highrisk or pre-malignant lesions. Anticancer Res 2001;21: 2895-2900.